Decisiondx®-melanoma provides improved risk stratification over american joint committee on cancer (ajcc) staging alone in stage i melanoma patients

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced data showing decisiondx-melanoma can improve risk stratification over ajcc staging alone in patients with stage i cutaneous melanoma.

CSTL Ratings Summary

CSTL Quant Ranking